NONOF 債券
以下是 Novo-Nordisk A/S 公司債券的清單。投資者通常選擇公司債券,因為它們在市場波動時具有更高的穩定性。研究價格、收益率和其他統計數據並找到可靠的投資。
商品 | YTM % | 成交量 | 價格 % | 票息 % | 到期日 | 未償金額 | 面值 | 最小面額金額 | 發行人 |
---|---|---|---|---|---|---|---|---|---|
XXS300255582NOVO NO.F.NL 25/37 MTN | 3.58% | 0 | 100.35% | 3.63% | 2037-05-27 | 1.25 B EUR | 1,000.00 EUR | 100,000.00 EUR | Novo Nordisk Finance (Netherlands) BV |
XXS282046075NOVO NO.F.NL 24/34 MTN | 3.29% | 0 | 100.55% | 3.38% | 2034-05-21 | 1.35 B EUR | 1,000.00 EUR | 100,000.00 EUR | Novo Nordisk Finance (Netherlands) BV |
XXS300255353NOVO NO.F.NL 25/33 MTN | 3.17% | 0 | 99.71% | 3.13% | 2033-05-27 | 900 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novo Nordisk Finance (Netherlands) BV |
XXS300255329NOVO NO.F.NL 25/30 MTN | 2.87% | 0 | 100.03% | 2.88% | 2030-08-27 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Novo Nordisk Finance (Netherlands) BV |
XXS282045567NOVO NO.F.NL 24/31 MTN | 2.79% | 0 | 102.18% | 3.25% | 2031-01-21 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Novo Nordisk Finance (Netherlands) BV |
2.73% | 0 | 94.34% | 1.38% | 2030-03-31 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novo Nordisk Finance (Netherlands) BV | |
XXS300255299NOVO NO.F.NL 25/28 MTN | 2.55% | 0 | 99.55% | 2.38% | 2028-05-27 | 1.45 B EUR | 1,000.00 EUR | 100,000.00 EUR | Novo Nordisk Finance (Netherlands) BV |
XXS300255213NOVO NO.F.NL 25/27 FLRMTN | 2.48% | 0 | 99.75% | 2.34% | 2027-05-27 | 1.4 B EUR | 1,000.00 EUR | 100,000.00 EUR | Novo Nordisk Finance (Netherlands) BV |
XXS282045460NOVO NO.F.NL 24/29 MTN | 2.47% | 0 | 102.13% | 3.13% | 2029-01-21 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Novo Nordisk Finance (Netherlands) BV |
2.36% | 0 | 93.97% | 0.13% | 2028-06-04 | 650 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novo Nordisk Finance (Netherlands) BV | |
2.30% | 0 | 97.53% | 1.13% | 2027-09-30 | 500 M EUR | 1,000.00 EUR | 100,000.00 EUR | Novo Nordisk Finance (Netherlands) BV | |
XXS282044994NOVO NO.F.NL 24/26 MTN | 2.30% | 0 | 100.89% | 3.38% | 2026-05-21 | 1.3 B EUR | 1,000.00 EUR | 100,000.00 EUR | Novo Nordisk Finance (Netherlands) BV |